Pharmaceuticals


Danes are living longer. And we can treat more diseases, because new and better drugs are entering the market all the time. This is good. But it’s expensive. Therefore, it's important that we are at the forefront of market developments, partly in order for new drugs to be put to use quickly, but also to realise savings related to analogue or generic alternatives.

Click here to read more about our tendering procedures

Certain patient groups have special needs. For example, children or cancer patients. Therefore, it is important that hospital pharmacies themselves can manufacture and prepare pharmaceuticals specifically for these patients. We help hospital pharmacies with this task.

Development of local health services also means that more, and more complicated, treatments have to be available to patients at home. This requires that the hospital pharmacies prepare medicines so that it is easier to use them at home.

Photographer: Anne-Li Engström


Large savings on medicine

Amgros has just completed its largest-ever tendering procedure for biological pharmaceuticals, including the world's top-selling drug: Humira. Now it is time to realise the savings as quickly as possible. Denmark is so efficient that other countries refer to us as a centre of excellence.

With the new contracts, Amgros expects savings of at least DKK 420 million next year. Now that the contracts with the suppliers have been signed, it is time to realise the savings as quickly as possible. This cannot be achieved until physicians at Danish hospitals start using the new and far less expensive drugs.

Denmark has very good experience with switching to new drugs. In fact, we are so good that other countries have been drawing lessons from us for a long time, and they are now referring to Denmark as a centre of excellence in the art of implementing new biosimilar drugs and reaping major savings fast.

Read more

Pharmaceuticals

Horizon Scanning

With Horizon Scanning, Amgros creates a comprehensive overview of new medicines and indication extensions expected to be marketed in Denmark within the next two to three years. This overview enables the Danish Medicines Council to plan its work well in advance. At the same time, it provides Amgros with a stronger basis for preparing upcoming price negotiations with suppliers and organising tendering procedures. We also prepare financial estimates that give the regions a solid foundation for planning their medicine budgets. These estimates take into account both new, often more expensive treatments and potential savings when lower-cost alternatives enter the market.

READ MORE
Pharmaceuticals

Price negotiations and tendering

Amgros is responsible for the procurement of the majority of medicines used in public Danish hospitals. In addition, we negotiate prices for selected medicines for the primary healthcare sector.

READ MORE
Pharmaceuticals

Procurement and supply

Amgros informs the hospital pharmacies when we have set up an agreement to purchase a pharmaceutical. After this, hospital pharmacies send their purchase orders to the supplier

READ MORE
Pharmaceuticals

SAD and magistral pharmaceuticals

SAD pharmaceuticals generally cover patients with special needs, and in many cases they cannot be purchased from the industry.

READ MORE